Organovo

$8.41
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.31 (-3.56%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Organovo and other stocks, options, and ETFs commission-free!

About ONVO

Organovo Holdings, Inc. engages in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.

CEO
Keith Murphy
Employees
6
Headquarters
San Diego, California
Founded
2012
Market Cap
62.53M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
129.83K
High Today
$8.90
Low Today
$8.31
Open Price
$8.90
Volume
135.80K
52 Week High
$23.92
52 Week Low
$5.80

ONVO Earnings

-$1.36
-$0.91
-$0.45
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected May 27, After Hours

You May Also Like

HUSN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure